Enlitic (ASX:ENL) announced a US$1.2 million imaging data migration contract with Parkland Health in Dallas, Texas.
Secured through a competitive tender process, the agreement task Enlitic with supporting the replacement of Parkland’s Vendor Neutral Archive.
The deal represents the third material contract signed by the company in March alone, bringing the collective monthly value of new agreements to US$3 million.
Under the contract’s terms, Enlitic will deploy its proprietary AI-powered data management platform, Ensight, to migrate and standardise approximately nine million legacy imaging studies.
There is further potential to expand this scope to 13 million studies, providing a pathway for additional revenue.
Standardisation is a pivotal component of the project, as it transforms inconsistent legacy data into clean, structured datasets that improve clinical workflows and facilitate the deployment of advanced analytics.
The deal is expected to provide an immediate boost, with roughly 90% of the contract’s revenue projected to be realised within the current calendar year.
By partnering with a leading counterparty like the Dallas County Hospital District, Enlitic further validates its capability to execute large-scale, complex enterprise migrations.
At the time of reporting, Enlitic's share price was $0.010.